Skip to Content
Merck

1.03893

Benzenesulfonic acid

EMPROVE® EXPERT

Synonym(s):

Benzene sulphonic acid, Benzenesulphonic acid, Besylic acid, Phenylsulfonic acid, Phenylsulphonic acid

Sign In to View Organizational & Contract Pricing.

Select a Size

500 G

CZK 38,200.00

1 KG

CZK 63,900.00

CZK 38,200.00


Please contact Customer Service for Availability

Request a Bulk OrderRequest a Sample

About This Item

Linear Formula:
C6H5SO3H
CAS Number:
Molecular Weight:
158.18
EC Number:
202-638-7
UNSPSC Code:
12352005
MDL number:
Beilstein/REAXYS Number:
742513

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI key

SRSXLGNVWSONIS-UHFFFAOYSA-N

InChI

1S/C6H6O3S/c7-10(8,9)6-4-2-1-3-5-6/h1-5H,(H,7,8,9)

SMILES string

OS(=O)(=O)c1ccccc1

biological source

synthetic

product line

EMPROVE® EXPERT

form

crystalline

technique(s)

API processing | cocrystal formation: suitable, API processing | salt formation: suitable

impurities

endotoxins, low

application(s)

liquid formulation
parenterals
pharmaceutical

Quality Level

Looking for similar products? Visit Product Comparison Guide

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
8.0046812635135070
application(s)

liquid formulation
parenterals
pharmaceutical

application(s)

-

application(s)

-

application(s)

-

technique(s)

API processing | cocrystal formation: suitable, API processing | salt formation: suitable

technique(s)

-

technique(s)

-

technique(s)

-

form

crystalline

form

solid

form

solid

form

solid

product line

EMPROVE® EXPERT

product line

-

product line

-

product line

-

biological source

synthetic

biological source

-

biological source

-

biological source

-

impurities

endotoxins, low

impurities

-

impurities

≤1.0% water

impurities

-

General description

For protein-based therapeutics, such as monoclonal antibodies (mAbs) or plasma derived proteins, often highly concentrated protein formulations are required to meet intended dosing regimens. However, this usually comes with elevated viscosities and presents a challenge in the manufacturing process and final formulation. Our Viscosity Reduction Excipient Platform reduces the viscosity and helps overcome challenges associated with highly concentrated protein solutions.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation.
Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

Application

The Viscosity Reduction Platform is based on the combination of two new excipients, one amino acid component with one anionic component, that together can better reduce protein viscosity beyond levels achieved with single excipients. Also, combining the two components enables a balance of viscosity reduction and protein stabilization. Benzenesulfonic Acid Emprove® Expert is part of this new proprietary technology platform.

Packaging

1038930500 / 500g / Glass bottle
1038931000 / 1kg / Glass bottle

Legal Information

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

pictograms

CorrosionExclamation mark

signalword

Danger

hcodes

Hazard Classifications

Acute Tox. 4 Oral - Eye Dam. 1 - Skin Corr. 1B

Storage Class

8A - Combustible corrosive hazardous materials

wgk

WGK 1


Stay compliant with GMP using the Emprove® Program

Accelerate qualification, maintain compliance, and save time with Emprove® Dossiers.

Download Dossiers

Note: you will be brought to EmproveSuite.com. Your username and password are separate from SigmaAldrich.com and may differ.

Register for free and access Emprove® Dossiers within minutes. Upgrade your subscription plan to unlock advanced and customized content in the Emprove® Suite

Not finding what you are looking for? Visit the Emprove® Program Help page.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Articles

This overview describes how use of viscosity-reducing excipients can address viscosity challenges in high concentration tangential flow filtration (TFF) and improve process economics.

Instead of addressing API solubility during formulation, tackle it early during development. Read about the various methods for API processing.

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service